Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05412 (
c-Jun
)
11,453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To delineate the functional role of the tumor necrosis factor-alpha (TNF-alpha) activator protein-1 (AP-1)/cAMP-responsive element (CRE)-like binding element (
TAC
), we transfected the TNF-alpha promoter lacking
TAC
into THP-1 monocytic cells and stimulated with lipopolysaccharide (LPS). Chloramphenicol acetyltransferase (CAT) activity was reduced by 22-fold, suggesting that
TAC
plays a role in LPS induction of the TNF-alpha promoter. Exposure to LPS resulted in the maximum release of soluble TNF-alpha by 2 h. Electrophoretic mobility shift assays (EMSA) using the
TAC
element as a probe showed a unique pattern for LPS-activated cells: the disappearance of the upper band of a doublet seen in untreated and all-trans retinoic acid (ATRA)-treated cells. Supershift analysis identified
c-Jun
and activating transcription factor-2 (ATF-2) as components of the LPS-stimulated binding complex. Jun N-terminal kinase (JNK), a known phosphorylator of
c-Jun
and ATF-2, increased in activity in LPS-stimulated monocytes. ATRA, on the contrary, did not activate JNK activity up to 72 h. Nuclear extracts from LPS-stimulated cells showed an increase in phosphorylated
c-Jun
by immunoblotting. Likewise, phosphorylated
c-Jun
bound to the
TAC
element, suggesting that
c-Jun
is activated by JNK to transactivate the TNF-alpha promoter in LPS-treated monocytes. Thus, phosphorylated
c-Jun
and ATF-2 play a role in activating the
TAC
element of the TNF-alpha promoter.
...
PMID:A distinct element involved in lipopolysaccharide activation of the tumor necrosis factor-alpha promoter in monocytes. 1095 18
Cardiac stress consistently activates
c-Jun
NH(2)-terminal kinase (JNK) pathways, however the role of different members of the JNK family is unclear. In this study, we applied pressure overload (
TAC
) in mice with selective deletion of the three JNK genes (Jnk1(-/-), Jnk2(-/-), and Jnk3(-/-)). Following
TAC
, all three JNK knockout mouse lines developed cardiac hypertrophy similar to wild-type mice (WT), but only JNK1(-/-) mice displayed a significant reduction in fractional shortening after 3 and 7 days of pressure overload, associated with a significant increase in terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling staining and marked inflammatory infiltrate. After the acute deterioration stage, JNK1(-/-) mice underwent a slow recovery followed by a steady progression of cardiac dysfunction, becoming indistinguishable from WT after 12 weeks of
TAC
. These data suggest that JNK1 plays a protective role in response to pressure overload, preventing the early deterioration in cardiac function following an acute increase in afterload.
...
PMID:JNK1 is required to preserve cardiac function in the early response to pressure overload. 1657 67